Represented biotech company ArcherDX in a jury trial in Delaware federal court. Jury found that European genetic testing company Qiagen willfully infringed a pair of patents owned by ArcherDX and Massachusetts General Hospital, awarding royalties and lost profits totaling about $4.7 million.